-
Recent Posts
Archives
- May 2018
- January 2018
- September 2017
- July 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- March 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- September 2013
- August 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
Categories
Blogroll
Tag Archives: Pfizer
Some observations regarding companies that should know better
Welcome to the Jurassic Petting Zoo Dinosaurs once roamed and ruled the earth, but they couldn’t take the heat. Similarly, Pfizer is exiting neuroscience R&D, with the exception of a couple of pain and rare disease programs, since they reside … Continue reading
Posted in Big Pharma, BioFollies, Biotech
Tagged Allergan, Axovant, esketamine, intepirdine, Janssen, Neuroscience, Pfizer, Pharma, Roche, Sanofi, Shire
Leave a comment
Pfallergan Round II?
<<Trump Executive Order Could Revive Allergan-Pfizer Merger -Emily Stewart TheStreet.com April 22, 2017 The Trump administration’s executive order on tax regulations could revive the defunct Allergan-Pfizer merger. The White House on Friday unveiled a new executive order instructing the Treasury … Continue reading
A Fond Farewell to My Cali-Irish Lass
My Dearest Allergan: The last few months have felt like a dream–you and I idling away the hours by the Irish Sea, picking out a spot for our new corporate cottage, singing the names of the staff we were going … Continue reading
A Thanksgiving Message from Pfallergan
As the United States prepares to celebrate Thanksgiving, a holiday that traditionally mixes gratitude and gluttony in relatively even proportions, we at Pfallergan would like to say how grateful we are for the fortuitous conjoining of our two constituent companies. … Continue reading
The Pfallergan Phallacy
(from NP Nov-Dec, released 10/31/15) As this issue of NP is released, the business media world is all aflutter with news that Pfizer and Allergan are discussing a merger. The headlines emphasize the massive scale of the potential alliance and … Continue reading
Pretzeled Peristalsis
The current spasm of M&A peristalsis just keeps yielding more data about the twisted logic so popular these days within the pharma industry and its institutional investors.Today’s sampling comes from Bloomberg.com, a piece written by Hallam and Kitamura, where they … Continue reading
Pharma New Math: Harvard+MIT>Yale
The Pharma industry has no lack of leaders whose creative vision extends only to the backside of the company walking directly in front of them. Consider the latest corporate substitute for originality, the belief that location and proximity are the … Continue reading
